Physiologic versus pathologic hypertrophy and the pressure-overloaded myocardium.

Area of Science:

• Cardiovascular Physiology
• Cardiac Remodeling
• Heart Failure Pathogenesis

Background:

• Myocardial mass increases with elevated systolic tension, primarily due to myocyte size.
• Hypertrophy involves complex remodeling of muscular, collagenous, and vascular compartments.
• Remodeling processes may occur asynchronously across different myocardial compartments.

Purpose of the Study:

• To delineate the distinct phases of myocardial hypertrophy.
• To characterize the structural and functional changes within each phase.
• To differentiate cardiac failure from congestive heart failure.

Main Methods:

• Conceptual framework based on existing knowledge of myocardial adaptation.
• Analysis of structural and biochemical remodeling in myocardial compartments.
• Correlation of functional parameters (contractility, pump function, O2 delivery) with hypertrophic phases.

Main Results:

• Evolutionary phase: remodeling in transition, preserved pump function and O2 delivery.
• Physiologic phase: coordinated remodeling, normal ventricular function, potential abnormal contractility indices.
• Pathologic phase: imbalanced remodeling, depressed contractility, impaired pump function and O2 delivery, potentially irreversible changes.

Conclusions:

• Myocardial hypertrophy is a continuum with identifiable evolutionary, physiologic, and pathologic phases.
• The pathologic phase is characterized by irreversible changes, impaired cardiac function, and reduced oxygen supply.
• Congestive heart failure is a late manifestation of chronic pressure overload and pathologic hypertrophy, distinct from primary cardiac failure.